activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650585	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1650585	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3830	Homo sapiens	Kd		
	1650586	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2300.0	CHEMBL3830	Homo sapiens	Kd	uM	2.3
Not Active	1650587	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3830	Homo sapiens	Kd		
	1650588	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	130.0	CHEMBL3830	Homo sapiens	Kd	uM	0.13
Not Active	1650589	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3830	Homo sapiens	Kd		
	1650590	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	960.0	CHEMBL3830	Homo sapiens	Kd	uM	0.96
Not Active	1650591	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1650592	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1650593	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3830	Homo sapiens	Kd		
	1651720	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.3	CHEMBL3830	Homo sapiens	Kd	uM	0.0013
Not Active	1651721	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1651722	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1651723	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1651724	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3830	Homo sapiens	Kd		
	1651725	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	35.0	CHEMBL3830	Homo sapiens	Kd	uM	0.035
Not Active	1651726	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1651727	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3830	Homo sapiens	Kd		
	1651728	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	4400.0	CHEMBL3830	Homo sapiens	Kd	uM	4.4
Not Active	1651729	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL3830	Homo sapiens	Kd		
Not Active	1651730	CHEMBL860786	Average Binding Constant for AAK1; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL3830	Homo sapiens	Kd		
	2470076	CHEMBL1033208	Inhibition of AAK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3830	Homo sapiens	INH	%	10.0
Active	2476589	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL3830	Homo sapiens	Activity		
Not Evaluated	2476792	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3830	Homo sapiens	Activity		
	2477865	CHEMBL986215	Binding affinity to human AAK1	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Kd	nM	53.0	CHEMBL3830	Homo sapiens	Kd	nM	53.0
Not Evaluated	2478631	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3830	Homo sapiens	Activity		
	2478834	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	1.1	CHEMBL3830	Homo sapiens	Activity	%	1.1
	2479689	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.2	CHEMBL3830	Homo sapiens	Activity	%	0.2
	2480688	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL3830	Homo sapiens	Activity	%	0.1
	2577310	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	13.8	CHEMBL3830	Homo sapiens	Activity	%	13.8
	2577513	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	33.3	CHEMBL3830	Homo sapiens	Activity	%	33.3
	2593515	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	1.8	CHEMBL3830	Homo sapiens	Activity	%	1.8
Not Evaluated	2593718	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3830	Homo sapiens	Activity		
Not Evaluated	2593984	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3830	Homo sapiens	Activity		
Not Evaluated	2594927	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3830	Homo sapiens	Activity		
Not Evaluated	2595130	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3830	Homo sapiens	Activity		
Not Evaluated	2595196	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3830	Homo sapiens	Activity		
	2596327	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	0.2	CHEMBL3830	Homo sapiens	Activity	%	0.2
	2597596	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	1.5	CHEMBL3830	Homo sapiens	Activity	%	1.5
Not Evaluated	2597799	CHEMBL993453	Binding affinity to human AAK1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3830	Homo sapiens	Activity		
	2894773	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894774	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894775	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894776	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894777	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894778	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894779	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	170.0	CHEMBL3830	Homo sapiens	Kd	nM	170.0
	2894780	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894781	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894782	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894783	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894784	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894785	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	3500.0	CHEMBL3830	Homo sapiens	Kd	nM	3500.0
	2894786	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1200.0	CHEMBL3830	Homo sapiens	Kd	nM	1200.0
	2894787	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	5300.0	CHEMBL3830	Homo sapiens	Kd	nM	5300.0
	2894788	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894789	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894790	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2900.0	CHEMBL3830	Homo sapiens	Kd	nM	2900.0
	2894791	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894792	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	200.0	CHEMBL3830	Homo sapiens	Kd	nM	200.0
	2894793	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894794	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	900.0	CHEMBL3830	Homo sapiens	Kd	nM	900.0
	2894795	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894796	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894797	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894798	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	48.0	CHEMBL3830	Homo sapiens	Kd	nM	48.0
	2894799	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894800	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894801	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894802	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894803	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894804	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894805	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.2	CHEMBL3830	Homo sapiens	Kd	nM	1.2
	2894806	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	66.0	CHEMBL3830	Homo sapiens	Kd	nM	66.0
	2894807	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	11.0	CHEMBL3830	Homo sapiens	Kd	nM	11.0
	2894808	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	290.0	CHEMBL3830	Homo sapiens	Kd	nM	290.0
	2894809	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2894810	CHEMBL1037546	Binding constant for AAK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	2921800	CHEMBL1056832	Inhibition of AAK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	92.0	CHEMBL3830	Homo sapiens	Activity	%	92.0
	3186255	CHEMBL1111490	Inhibition of AAK1	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Kd	nM	53.0	CHEMBL3830	Homo sapiens	Kd	nM	53.0
	3331804	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3333219	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3334624	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3336044	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3337432	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3337680	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3339011	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3339267	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3340572	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3341988	CHEMBL1168572	Inhibition of AAK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3830	Homo sapiens	INH	%	50.0
	3358425	CHEMBL1174039	Inhibition of AAK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	99.0	CHEMBL3830	Homo sapiens	INH	%	99.0
	3358867	CHEMBL1174039	Inhibition of AAK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	59.0	CHEMBL3830	Homo sapiens	INH	%	59.0
	3445015	CHEMBL1244701	Binding affinity to AAK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.1	CHEMBL3830	Homo sapiens	Kd	nM	3.1
Not Active	3446216	CHEMBL1244356	Inhibition of AAK1	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		IC50			CHEMBL3830	Homo sapiens	IC50		
	3448874	CHEMBL1244701	Binding affinity to AAK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	48.0	CHEMBL3830	Homo sapiens	Kd	nM	48.0
	3449083	CHEMBL1244701	Binding affinity to AAK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	11.0	CHEMBL3830	Homo sapiens	Kd	nM	11.0
	3449084	CHEMBL1244701	Binding affinity to AAK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	960.0	CHEMBL3830	Homo sapiens	Kd	nM	960.0
	3449538	CHEMBL1244701	Binding affinity to AAK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	3449963	CHEMBL1244701	Binding affinity to AAK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	3451191	CHEMBL1244701	Binding affinity to AAK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	uM	10.0
	6339903	CHEMBL1826201	Activity of AAK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	64.0	CHEMBL3830	Homo sapiens	Activity	%	64.0
	7567506	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7567977	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7568445	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7568877	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	66.0	CHEMBL3830	Homo sapiens	Kd	nM	66.0
	7569020	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7569480	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7569952	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7570415	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	320.0	CHEMBL3830	Homo sapiens	Kd	nM	320.0
	7570842	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	11.0	CHEMBL3830	Homo sapiens	Kd	nM	11.0
	7570996	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7571453	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2300.0	CHEMBL3830	Homo sapiens	Kd	nM	2300.0
	7571929	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	120.0	CHEMBL3830	Homo sapiens	Kd	nM	120.0
	7572392	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7572808	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	470.0	CHEMBL3830	Homo sapiens	Kd	nM	470.0
	7572977	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	2800.0	CHEMBL3830	Homo sapiens	Kd	nM	2800.0
	7573434	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7573910	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	520.0	CHEMBL3830	Homo sapiens	Kd	nM	520.0
	7574379	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	48.0	CHEMBL3830	Homo sapiens	Kd	nM	48.0
	7574955	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	63.0	CHEMBL3830	Homo sapiens	Kd	nM	63.0
	7575416	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1200.0	CHEMBL3830	Homo sapiens	Kd	nM	1200.0
	7575887	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7576318	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	870.0	CHEMBL3830	Homo sapiens	Kd	nM	870.0
	7576929	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7577388	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7577894	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7578299	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	35.0	CHEMBL3830	Homo sapiens	Kd	nM	35.0
	7578937	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	43.0	CHEMBL3830	Homo sapiens	Kd	nM	43.0
	7579311	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7579761	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	5300.0	CHEMBL3830	Homo sapiens	Kd	nM	5300.0
	7579793	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	48.0	CHEMBL3830	Homo sapiens	Kd	nM	48.0
	7580262	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1600.0	CHEMBL3830	Homo sapiens	Kd	nM	1600.0
	7580665	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7581295	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7581680	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7582154	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7582618	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7583018	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	290.0	CHEMBL3830	Homo sapiens	Kd	nM	290.0
	7584041	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7584512	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	2700.0	CHEMBL3830	Homo sapiens	Kd	nM	2700.0
	7584974	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	410.0	CHEMBL3830	Homo sapiens	Kd	nM	410.0
	7585378	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7585529	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7585937	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7586383	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	9100.0	CHEMBL3830	Homo sapiens	Kd	nM	9100.0
	7586854	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	900.0	CHEMBL3830	Homo sapiens	Kd	nM	900.0
	7587308	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7587490	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7587909	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7588362	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7588833	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7589284	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7589455	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1200.0	CHEMBL3830	Homo sapiens	Kd	nM	1200.0
	7589879	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.1	CHEMBL3830	Homo sapiens	Kd	nM	3.1
	7590346	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7590820	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7591428	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7591850	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	170.0	CHEMBL3830	Homo sapiens	Kd	nM	170.0
	7592322	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7592806	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7593395	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7593830	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7594302	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7594333	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7594785	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	2300.0	CHEMBL3830	Homo sapiens	Kd	nM	2300.0
	7595363	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7595807	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7596310	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7596757	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7597335	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	3000.0	CHEMBL3830	Homo sapiens	Kd	nM	3000.0
	7597819	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3830	Homo sapiens	Kd	nM	10000.0
	7598289	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2900.0	CHEMBL3830	Homo sapiens	Kd	nM	2900.0
	7598731	CHEMBL1908786	Binding constant for AAK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.2	CHEMBL3830	Homo sapiens	Kd	nM	1.2
	8012925	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCN(C(=O)OC(C)(C)C)CC1)NC2=O		CHEMBL1945558	=	Delta Tm	degrees C	0.3	CHEMBL3830	Homo sapiens	deltaTm	degrees C	0.3
	8012949	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	1.5	CHEMBL3830	Homo sapiens	deltaTm	degrees C	1.5
	8012973	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	N#CC1c2c([nH]c3c(Cl)c(Cl)ccc23)C(=O)NC12CCCCC2		CHEMBL1945560	=	Delta Tm	degrees C	2.4	CHEMBL3830	Homo sapiens	deltaTm	degrees C	2.4
	8012997	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O		CHEMBL1945561	=	Delta Tm	degrees C	0.8	CHEMBL3830	Homo sapiens	deltaTm	degrees C	0.8
	8013022	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C		CHEMBL1945562	=	Delta Tm	degrees C	0.2	CHEMBL3830	Homo sapiens	deltaTm	degrees C	0.2
	8026915	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21		CHEMBL474872	=	Delta Tm	degrees C	4.6	CHEMBL3830	Homo sapiens	deltaTm	degrees C	4.6
	8027526	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21		CHEMBL1945336	=	Delta Tm	degrees C	2.0	CHEMBL3830	Homo sapiens	deltaTm	degrees C	2.0
	8027551	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O		CHEMBL1945337	=	Delta Tm	degrees C	2.2	CHEMBL3830	Homo sapiens	deltaTm	degrees C	2.2
	8027576	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N		CHEMBL1945338	=	Delta Tm	degrees C	1.1	CHEMBL3830	Homo sapiens	deltaTm	degrees C	1.1
	8027601	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N		CHEMBL1945339	=	Delta Tm	degrees C	1.7	CHEMBL3830	Homo sapiens	deltaTm	degrees C	1.7
	8027626	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O		CHEMBL1945340	=	Delta Tm	degrees C	0.6	CHEMBL3830	Homo sapiens	deltaTm	degrees C	0.6
	8027651	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCCC1)NC2=O		CHEMBL1945341	=	Delta Tm	degrees C	1.7	CHEMBL3830	Homo sapiens	deltaTm	degrees C	1.7
	8027662	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O		CHEMBL1945554	=	Delta Tm	degrees C	1.5	CHEMBL3830	Homo sapiens	deltaTm	degrees C	1.5
	8027687	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O		CHEMBL1945335	=	Delta Tm	degrees C	2.6	CHEMBL3830	Homo sapiens	deltaTm	degrees C	2.6
	8027712	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cn[nH]c(=O)c21		CHEMBL1945555	=	Delta Tm	degrees C	3.9	CHEMBL3830	Homo sapiens	deltaTm	degrees C	3.9
	8027737	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556	=	Delta Tm	degrees C	0.9	CHEMBL3830	Homo sapiens	deltaTm	degrees C	0.9
	8027762	CHEMBL1948983	Binding affinity to AAK1 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945557	=	Delta Tm	degrees C	0.2	CHEMBL3830	Homo sapiens	deltaTm	degrees C	0.2
	8046121	CHEMBL1958807	Inhibition of AAK1 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	84.0	CHEMBL3830	Homo sapiens	INH	%	84.0
	12060543	CHEMBL2154880	Binding affinity to AAK1	B	Nc1nc2c(-c3ccccn3)nccc2[nH]1		CHEMBL2153264	=	Kd	nM	1500.0	CHEMBL3830	Homo sapiens	Kd	nM	1500.0
	12173767	CHEMBL2212564	Inhibition of AAK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	67.0	CHEMBL3830	Homo sapiens	Activity	%	67.0
	12185218	CHEMBL2216361	Inhibition of AAK1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	=	IC50	nM	5888.44	CHEMBL3830	Homo sapiens	pIC50		5.23
	13342308	CHEMBL2394179	Competitive binding affinity to AAK1 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2ccnc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1898211	<	Activity	%	30.0	CHEMBL3830	Homo sapiens	Activity	%	30.0
	13442409	CHEMBL2428032	Competitive binding affinity to AAK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	70.0	CHEMBL3830	Homo sapiens	INH	%	70.0
	13445544	CHEMBL2428032	Competitive binding affinity to AAK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	99.0	CHEMBL3830	Homo sapiens	INH	%	99.0
	13448599	CHEMBL2428032	Competitive binding affinity to AAK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	95.0	CHEMBL3830	Homo sapiens	INH	%	95.0
	13448736	CHEMBL2428032	Competitive binding affinity to AAK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	98.0	CHEMBL3830	Homo sapiens	INH	%	98.0
	13451531	CHEMBL2428032	Competitive binding affinity to AAK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	99.0	CHEMBL3830	Homo sapiens	INH	%	99.0
	13454715	CHEMBL2428032	Competitive binding affinity to AAK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	98.0	CHEMBL3830	Homo sapiens	INH	%	98.0
	13895052	CHEMBL3112125	Inhibition of AAK1 (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	77.0	CHEMBL3830	Homo sapiens	Activity	%	77.0
	13946511	CHEMBL3130077	Inhibition of AAK1 (unknown origin) at 2.5 uM after 20 mins	B	NS(=O)(=O)OCCn1cnc2c(Nc3ccc(F)cc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21		CHEMBL3125667	=	Inhibition	%	52.0	CHEMBL3830	Homo sapiens	INH	%	52.0
	15002486	CHEMBL3366562	Inhibition of AAK1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	18.0	CHEMBL3830	Homo sapiens	Activity	%	18.0
	15250380	CHEMBL3430284	Binding affinity to human AAK1 at 10 uM relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Activity	%	90.0	CHEMBL3830	Homo sapiens	Activity	%	90.0
Active	17878157	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	102.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	102.0
Inactive	17878158	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878159	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	363.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	363.0
Inactive	17878160	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878161	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878162	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878163	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878164	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	1325.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1325.0
Inactive	17878165	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878166	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878167	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878168	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	138.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	138.0
Inactive	17878169	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878170	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	413.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	413.0
Inactive	17878171	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878172	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878173	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878174	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	1174.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1174.0
Active	17878175	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	9.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	9.0
Inactive	17878176	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878177	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878178	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878179	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878180	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878181	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878182	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878183	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878184	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878185	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878186	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878187	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878188	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878189	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878190	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878191	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878192	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	7413.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	7413.0
Inactive	17878193	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878194	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878195	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878196	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878197	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878198	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878199	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878200	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878201	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878202	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878203	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878204	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878205	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878206	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	73.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	73.0
Inactive	17878207	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878208	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	6.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	6.0
Inactive	17878209	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878210	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878211	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	25.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	25.0
Inactive	17878212	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878213	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	318.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	318.0
Inactive	17878214	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878215	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878216	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878217	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	42.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	42.0
Inactive	17878218	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878219	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878220	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878221	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878222	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878223	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878224	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878225	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	Kd	nM	3647.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	3647.0
Active	17878226	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	209.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	209.0
Active	17878227	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	Kd	nM	228.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	228.0
Inactive	17878228	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878229	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878230	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878231	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878232	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878233	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878234	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878235	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878236	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878237	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878238	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878239	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	623.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	623.0
Inactive	17878240	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878241	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878242	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	4.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	4.0
Inactive	17878243	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878244	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878245	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878246	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	Kd	nM	1279.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1279.0
Inactive	17878247	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878248	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878249	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	1.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1.0
Active	17878250	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	172.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	172.0
Inactive	17878251	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878252	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878253	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	2.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	2.0
Inactive	17878254	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878255	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878256	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	Kd	nM	1069.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1069.0
Inactive	17878257	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878258	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	22.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	22.0
Inactive	17878259	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878260	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878261	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878262	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878263	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	17.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	17.0
Inactive	17878264	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878265	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878266	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878267	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878268	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878269	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878270	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878271	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878272	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878273	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	253.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	253.0
Inactive	17878274	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878275	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878276	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878277	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878278	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878279	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878280	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878281	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878282	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878283	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878284	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878285	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878286	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	4253.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	4253.0
Uncertain	17878287	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1471.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1471.0
Inactive	17878288	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878289	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878290	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878291	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	353.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	353.0
Inactive	17878292	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878293	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878294	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878295	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878296	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878297	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878298	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878299	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878300	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878301	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878302	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	3345.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	3345.0
Inactive	17878303	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878304	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878305	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878306	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878307	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878308	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878309	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878310	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1414.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1414.0
Active	17878311	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	401.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	401.0
Inactive	17878312	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878313	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878314	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878315	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878316	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	2608.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	2608.0
Inactive	17878317	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878318	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	66.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	66.0
Inactive	17878319	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878320	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878321	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878322	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17878323	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Kd	nM	4216.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	4216.0
Inactive	17878324	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878325	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878326	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878327	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878328	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878329	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	359.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	359.0
Inactive	17878330	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878331	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878332	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878333	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878334	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878335	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878336	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878337	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878338	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1351.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1351.0
Active	17878339	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	Kd	nM	2441.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	2441.0
Inactive	17878340	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878341	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878342	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878343	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	6.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	6.0
Inactive	17878344	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878345	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878346	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878347	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878348	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878349	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	5.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	5.0
Inactive	17878350	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878351	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	122.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	122.0
Inactive	17878352	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878353	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878354	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878355	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878356	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878357	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878358	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878359	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878360	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878361	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878362	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	35.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	35.0
Inactive	17878363	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878364	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878365	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878366	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878367	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	=	Kd	nM	22238.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	22238.0
Inactive	17878368	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878369	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878370	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878371	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878372	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	=	Kd	nM	13711.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	13711.0
Inactive	17878373	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878374	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	46.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	46.0
Inactive	17878375	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878376	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878377	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	Kd	nM	4990.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	4990.0
Inactive	17878378	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878379	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1476.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	1476.0
Inactive	17878380	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878381	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	=	Kd	nM	12.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	12.0
Inactive	17878382	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878383	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878384	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878385	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878386	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	3041.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	3041.0
Inactive	17878387	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878388	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878389	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878390	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878391	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878392	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878393	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878394	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878395	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878396	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878397	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
Active	17878398	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	2159.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	2159.0
Inactive	17878399	CHEMBL3991602	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3830	Homo sapiens	Kd apparent	nM	30000.0
	18105553	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	CC(C)C[C@](C)(N)COc1ccc(-c2ccnc3ccccc23)cc1C1CC1		CHEMBL4085072	=	IC50	nM	0.07	CHEMBL3830	Homo sapiens	IC50	nM	0.07
	18105554	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	Cc1cc(-c2ccc(OC[C@@](C)(N)CC(C)C)c(S(C)(=O)=O)c2)ccn1		CHEMBL4103020	=	IC50	nM	1400.0	CHEMBL3830	Homo sapiens	IC50	nM	1400.0
	18105555	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	Cc1cc(-c2cc(C(F)F)c(OC[C@@](C)(N)CC(C)C)cn2)ccn1		CHEMBL4092824	=	IC50	nM	0.51	CHEMBL3830	Homo sapiens	IC50	nM	0.51
	18105556	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	CC(C)C[C@](C)(N)COc1ncc(-c2ccnc3ccccc23)cc1C(F)F		CHEMBL4065155	=	IC50	nM	0.23	CHEMBL3830	Homo sapiens	IC50	nM	0.23
	18105557	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	CC(C)C[C@](C)(N)COc1ccc(-c2ccnc(C(C)C)n2)cc1F		CHEMBL4066208	=	IC50	nM	886.0	CHEMBL3830	Homo sapiens	IC50	nM	886.0
	18105558	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	COc1cc(-c2ccnc(NC(C)=O)c2)ccc1OC[C@@H](N)CC(C)C		CHEMBL4073745	=	IC50	nM	3.0	CHEMBL3830	Homo sapiens	IC50	nM	3.0
	18105559	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	COC(=O)Nc1cc(-c2ccc(OC[C@@](C)(N)CC(C)C)c(C3CC3)c2)ccn1		CHEMBL4084103	=	IC50	nM	0.32	CHEMBL3830	Homo sapiens	IC50	nM	0.32
	18105560	CHEMBL4022632	Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs	B	CC(=O)Nc1cc(-c2ccc(OC[C@@H](N)CC(C)C)c(C)c2)ccn1		CHEMBL4062388	=	IC50	nM	0.42	CHEMBL3830	Homo sapiens	IC50	nM	0.42
	18114512	CHEMBL4024982	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	96.0	CHEMBL3830	Homo sapiens	Activity	%	96.0
	18203418	CHEMBL4043793	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3830	Homo sapiens	Activity	%	100.0
	18253347	CHEMBL4054957	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	63.0	CHEMBL3830	Homo sapiens	Activity	%	63.0
	18253348	CHEMBL4054957	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	73.0	CHEMBL3830	Homo sapiens	Activity	%	73.0
Active	18275803	CHEMBL4118763	Binding affinity to AAK1 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3830	Homo sapiens	Activity		
Active	18275948	CHEMBL4118908	Binding affinity to AAK1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3830	Homo sapiens	Activity		
	18440048	CHEMBL4156872	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	71.0	CHEMBL3830	Homo sapiens	Activity	%	71.0
	18484488	CHEMBL4185651	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL3830	Homo sapiens	Activity	%	100.0
	18485133	CHEMBL4185651	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL3830	Homo sapiens	Activity	%	99.0
	18655669	CHEMBL4230551	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3830	Homo sapiens	Activity	%	100.0
	18752074	CHEMBL4264140	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	99.0	CHEMBL3830	Homo sapiens	Activity	%	99.0
	18850836	CHEMBL4305761	Binding affinity to biotinylated AAK1 (unknown origin) incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based binding displacement assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	IC50	nM	1170.0	CHEMBL3830	Homo sapiens	IC50	uM	1.17
	18850837	CHEMBL4305761	Binding affinity to biotinylated AAK1 (unknown origin) incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based binding displacement assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Ki	nM	541.0	CHEMBL3830	Homo sapiens	Ki	uM	0.541
	18850847	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Kd	nM	120.0	CHEMBL3830	Homo sapiens	Kd	uM	0.12
	18850848	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	O=C(Nc1c[nH]c2ncc(-c3ccccc3)cc12)c1cccnc1		CHEMBL4590585	=	Kd	nM	82.2	CHEMBL3830	Homo sapiens	Kd	uM	0.0822
	18850849	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	O=C(Nc1c[nH]c2ncc(-c3ccc(F)cc3)cc12)c1cccnc1		CHEMBL4453393	=	Kd	nM	141.0	CHEMBL3830	Homo sapiens	Kd	uM	0.141
Not Determined	18850850	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	O=C(Nc1c[nH]c2ncc(-c3ccc(C(F)(F)F)cc3)cc12)c1cccnc1		CHEMBL4561278		Kd			CHEMBL3830	Homo sapiens	Kd		
	18850851	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL4450261	=	Kd	nM	19.4	CHEMBL3830	Homo sapiens	Kd	uM	0.0194
	18850852	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL4455428	=	Kd	nM	53.2	CHEMBL3830	Homo sapiens	Kd	uM	0.0532
Not Determined	18850853	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	Cc1cccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)c1		CHEMBL4483684		Kd			CHEMBL3830	Homo sapiens	Kd		
	18850854	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1OC		CHEMBL4541962	=	Kd	nM	6.73	CHEMBL3830	Homo sapiens	Kd	uM	0.00673
	18850855	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	O=C(Nc1c[nH]c2ncc(-c3ccsc3)cc12)c1cccnc1		CHEMBL4456500	=	Kd	nM	16.1	CHEMBL3830	Homo sapiens	Kd	uM	0.0161
	18850856	CHEMBL4305760	Binding affinity to wild type DNA-tagged human AAK1 (G25 to L333 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	11.0	CHEMBL3830	Homo sapiens	Kd	uM	0.011
Not Determined	18850857	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		IC50			CHEMBL3830	Homo sapiens	IC50		
Not Determined	18850858	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	O=C(Nc1c[nH]c2ncc(-c3ccccc3)cc12)c1cccnc1		CHEMBL4590585		IC50			CHEMBL3830	Homo sapiens	IC50		
Not Determined	18850859	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	O=C(Nc1c[nH]c2ncc(-c3ccc(F)cc3)cc12)c1cccnc1		CHEMBL4453393		IC50			CHEMBL3830	Homo sapiens	IC50		
	18850860	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	O=C(Nc1c[nH]c2ncc(-c3ccc(C(F)(F)F)cc3)cc12)c1cccnc1		CHEMBL4561278	=	IC50	nM	230.0	CHEMBL3830	Homo sapiens	IC50	uM	0.23
Not Determined	18850861	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL4450261		IC50			CHEMBL3830	Homo sapiens	IC50		
Not Determined	18850862	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL4455428		IC50			CHEMBL3830	Homo sapiens	IC50		
	18850863	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	Cc1cccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)c1		CHEMBL4483684	=	IC50	nM	18.6	CHEMBL3830	Homo sapiens	IC50	uM	0.0186
	18850864	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1OC		CHEMBL4541962	=	IC50	nM	4.32	CHEMBL3830	Homo sapiens	IC50	uM	0.00432
Not Determined	18850865	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	O=C(Nc1c[nH]c2ncc(-c3ccsc3)cc12)c1cccnc1		CHEMBL4456500		IC50			CHEMBL3830	Homo sapiens	IC50		
	18850866	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	47.4	CHEMBL3830	Homo sapiens	IC50	uM	0.0474
	18850867	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4ccccc4)c3c2)cc1OC		CHEMBL4444527	=	IC50	nM	108.0	CHEMBL3830	Homo sapiens	IC50	uM	0.108
	18850868	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4ccc(F)cc4)c3c2)cc1OC		CHEMBL4524476	=	IC50	nM	161.0	CHEMBL3830	Homo sapiens	IC50	uM	0.161
	18850869	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(C(=O)Nc2c[nH]c3ncc(-c4ccc(OC)c(OC)c4)cc23)cc1		CHEMBL4443908	=	IC50	nM	72.1	CHEMBL3830	Homo sapiens	IC50	uM	0.0721
	18850870	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4ccncc4)c3c2)cc1OC		CHEMBL4515873	=	IC50	nM	381.0	CHEMBL3830	Homo sapiens	IC50	uM	0.381
	18850871	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)Cc4ccccc4)c3c2)cc1OC		CHEMBL4553067	=	IC50	nM	612.0	CHEMBL3830	Homo sapiens	IC50	uM	0.612
	18850872	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)C4CCCC4)c3c2)cc1OC		CHEMBL4475520	=	IC50	nM	398.0	CHEMBL3830	Homo sapiens	IC50	uM	0.398
	18850873	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334981	=	IC50	nM	319.0	CHEMBL3830	Homo sapiens	IC50	uM	0.319
	18850874	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cc1OC		CHEMBL3102941	=	IC50	nM	23.6	CHEMBL3830	Homo sapiens	IC50	uM	0.0236
	18850875	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C(=O)c4ccccc4)c3c2)cc1OC		CHEMBL4474078	=	IC50	nM	184.0	CHEMBL3830	Homo sapiens	IC50	uM	0.184
	18850876	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4ccccc4)c3c2)cc1OC		CHEMBL4461527	=	IC50	nM	209.0	CHEMBL3830	Homo sapiens	IC50	uM	0.209
	18850877	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(NS(=O)(=O)c4ccccc4)c3c2)cc1OC		CHEMBL4476807	=	IC50	nM	4440.0	CHEMBL3830	Homo sapiens	IC50	uM	4.44
	18850878	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4cccnc4)c3c2)cc1OC		CHEMBL4439128	=	IC50	nM	4.02	CHEMBL3830	Homo sapiens	IC50	uM	0.00402
	18850879	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1cccc(C#Cc2c[nH]c3ncc(-c4ccc(OC)c(OC)c4)cc23)c1		CHEMBL4454007	=	IC50	nM	149.0	CHEMBL3830	Homo sapiens	IC50	uM	0.149
	18850880	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4ccc(C)cc4)c3c2)cc1OC		CHEMBL4449852	=	IC50	nM	420.0	CHEMBL3830	Homo sapiens	IC50	uM	0.42
	18850881	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4ccc(F)cc4)c3c2)cc1OC		CHEMBL4468845	=	IC50	nM	387.0	CHEMBL3830	Homo sapiens	IC50	uM	0.387
	18850882	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4cccc(C#N)c4)c3c2)cc1OC		CHEMBL4448513	=	IC50	nM	381.0	CHEMBL3830	Homo sapiens	IC50	uM	0.381
	18850883	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3c(c2)c(NC(=O)c2cccnc2)cn3C)cc1OC		CHEMBL4471240	=	IC50	nM	3390.0	CHEMBL3830	Homo sapiens	IC50	uM	3.39
	18850884	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]nc(NC(=O)c4cccnc4)c3c2)cc1OC		CHEMBL4529052	=	IC50	nM	462.0	CHEMBL3830	Homo sapiens	IC50	uM	0.462
	18850885	CHEMBL4305756	Displacement of tracer 222 from GST-tagged recombinant human AAK1 catalytic domain (1 to 510 amino acids) expressed in insect cells shaken for 30 secs and incubated for 1 hr by LanthaScreen Eu kinase binding assay	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4cccnc4)c3n2)cc1OC		CHEMBL4442812	=	IC50	nM	9.27	CHEMBL3830	Homo sapiens	IC50	uM	0.00927
	18850986	CHEMBL4305771	Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method	B	CC(C)C[C@](C)(N)COc1ccc(-c2ccnc3ccnn23)cc1C(F)F		CHEMBL4544854	=	IC50	nM	0.2	CHEMBL3830	Homo sapiens	IC50	nM	0.2
	18850987	CHEMBL4305771	Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method	B	CC(=O)Nc1cc(-c2ccc(OC[C@@H](N)CC(C)C)c(C#N)c2)ccn1		CHEMBL4534648	=	IC50	nM	0.3	CHEMBL3830	Homo sapiens	IC50	nM	0.3
	18850988	CHEMBL4305771	Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method	B	CCOC(=O)Nc1cc2c(cn1)OCc1cc(OC[C@@](C)(N)CC(C)C)ccc1-2		CHEMBL4559183	=	IC50	nM	0.62	CHEMBL3830	Homo sapiens	IC50	nM	0.62
	18850989	CHEMBL4305771	Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method	B	COc1cc2nc(C(N)CC(C)C)nc(C#N)c2cc1-c1cnco1		CHEMBL4543869	=	IC50	nM	6.0	CHEMBL3830	Homo sapiens	IC50	nM	6.0
	18850990	CHEMBL4305771	Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method	B	CC(C)C[C@@H](N)c1nc2cc(-c3ncnc4[nH]ccc34)ccc2[nH]1		CHEMBL4525214	=	IC50	nM	4.0	CHEMBL3830	Homo sapiens	IC50	nM	4.0
	18850991	CHEMBL4305771	Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method	B	CC(C)n1nnc(-c2cc(O)cc(Nc3ncnn4ccc(CN5CCC(N)CC5)c34)c2)n1		CHEMBL4541595	=	IC50	nM	3.3	CHEMBL3830	Homo sapiens	IC50	nM	3.3
Active	18851000	CHEMBL4305773	Inhibition of AAK1 in human HuH7 cells assessed as reduction in AP2M1 phosphorylation 2.5 to 10 uM pre-incubated for 4 hrs followed by PP2A inhibitor calyculin A addition and measured after 30 mins by Western blot analysis	B	COc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1OC		CHEMBL4541962		Inhibition	%		CHEMBL3830	Homo sapiens	INH		
Active	18851001	CHEMBL4305773	Inhibition of AAK1 in human HuH7 cells assessed as reduction in AP2M1 phosphorylation 2.5 to 10 uM pre-incubated for 4 hrs followed by PP2A inhibitor calyculin A addition and measured after 30 mins by Western blot analysis	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4cccnc4)c3c2)cc1OC		CHEMBL4439128		Inhibition	%		CHEMBL3830	Homo sapiens	INH		
Active	18851010	CHEMBL4305776	Inhibition of AAK1 in human HuH7 cells assessed as reduction in AP2M1 phosphorylation 5 to 10 uM pre-incubated for 4 hrs followed by PP2A inhibitor calyculin A addition and measured after 30 mins by Western blot analysis	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Inhibition	%		CHEMBL3830	Homo sapiens	INH		
	18857809	CHEMBL4307657	Binding affinity to wild-type human partial length AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL3830	Homo sapiens	Activity	%	100.0
	18892543	CHEMBL4314728	Inhibition of human AAK1 assessed as residual activity at 10 uM using peptide substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.0	CHEMBL3830	Homo sapiens	Activity	%	105.0
	18919503	CHEMBL4322860	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AAK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	6.0	CHEMBL3830	Homo sapiens	Kd	nM	6.0
	18919691	CHEMBL4322860	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AAK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	5.0	CHEMBL3830	Homo sapiens	Kd	nM	5.0
	18958712	CHEMBL4333251	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	16.0	CHEMBL3830	Homo sapiens	Activity	%	16.0
	18964035	CHEMBL4334951	Inhibition of human AAK1 assessed as residual activity at 1 uM using peptide as substrate incubated for 120 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	101.0	CHEMBL3830	Homo sapiens	Activity	%	101.0
	18971767	CHEMBL4336777	Inhibition of human AAK1 assessed as residual activity at 10 uM using peptide as substrate incubated for 120 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	78.0	CHEMBL3830	Homo sapiens	Activity	%	78.0
	19009094	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	IC50	nM	1200.0	CHEMBL3830	Homo sapiens	IC50	nM	1200.0
	19009095	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	NC(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4447579	=	IC50	nM	3800.0	CHEMBL3830	Homo sapiens	IC50	nM	3800.0
	19009096	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	NC(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL4456439	=	IC50	nM	910.0	CHEMBL3830	Homo sapiens	IC50	nM	910.0
	19009097	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CC(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4475820	=	IC50	nM	1100.0	CHEMBL3830	Homo sapiens	IC50	nM	1100.0
	19009098	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4440411	=	IC50	nM	18000.0	CHEMBL3830	Homo sapiens	IC50	nM	18000.0
	19009099	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL4070698	=	IC50	nM	2800.0	CHEMBL3830	Homo sapiens	IC50	nM	2800.0
	19009100	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL4094782	=	IC50	nM	350.0	CHEMBL3830	Homo sapiens	IC50	nM	350.0
	19009101	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	=	IC50	nM	280.0	CHEMBL3830	Homo sapiens	IC50	nM	280.0
	19009102	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4449317	=	IC50	nM	800.0	CHEMBL3830	Homo sapiens	IC50	nM	800.0
	19009103	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CN(c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1)S(C)(=O)=O		CHEMBL4587030	=	IC50	nM	120.0	CHEMBL3830	Homo sapiens	IC50	nM	120.0
	19009104	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4590146	=	IC50	nM	71.0	CHEMBL3830	Homo sapiens	IC50	nM	71.0
	19009105	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CC(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452093	=	IC50	nM	54.0	CHEMBL3830	Homo sapiens	IC50	nM	54.0
	19009106	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	=	IC50	nM	31.0	CHEMBL3830	Homo sapiens	IC50	nM	31.0
	19009107	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(CC1CC1)Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12		CHEMBL4442341	=	IC50	nM	3500.0	CHEMBL3830	Homo sapiens	IC50	nM	3500.0
	19009108	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CCC1		CHEMBL4472562	=	IC50	nM	370.0	CHEMBL3830	Homo sapiens	IC50	nM	370.0
	19009109	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CC(=O)Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12		CHEMBL4533288	=	IC50	nM	560.0	CHEMBL3830	Homo sapiens	IC50	nM	560.0
	19009110	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)c1ccccc1		CHEMBL4531247	=	IC50	nM	2200.0	CHEMBL3830	Homo sapiens	IC50	nM	2200.0
	19009111	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CN(C)C(=O)Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12		CHEMBL4543876	>	IC50	nM	50000.0	CHEMBL3830	Homo sapiens	IC50	nM	50000.0
	19009112	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CS(=O)(=O)Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12		CHEMBL4475067	>	IC50	nM	50000.0	CHEMBL3830	Homo sapiens	IC50	nM	50000.0
	19009113	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CC(C)S(=O)(=O)Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12		CHEMBL4591874	=	IC50	nM	7700.0	CHEMBL3830	Homo sapiens	IC50	nM	7700.0
	19009114	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	IC50	nM	220.0	CHEMBL3830	Homo sapiens	IC50	nM	220.0
	19009115	CHEMBL4345181	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system after 1 hr by split luciferase assay	B	CC(C)C(=O)Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12		CHEMBL4458078	=	IC50	nM	18000.0	CHEMBL3830	Homo sapiens	IC50	nM	18000.0
	19009116	CHEMBL4345182	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system at 1 uM after 1 hr by split luciferase assay relative to control	B	CN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452360	=	Inhibition	%	93.0	CHEMBL3830	Homo sapiens	INH	%	93.0
	19009117	CHEMBL4345182	Inhibition of AAK1 (unknown origin) using Fos-Nfluc, Cfluc-kinase and rabbit reticulate lysate system at 1 uM after 1 hr by split luciferase assay relative to control	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4534959	=	Inhibition	%	94.0	CHEMBL3830	Homo sapiens	INH	%	94.0
	19009118	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	=	Ki	nM	8.3	CHEMBL3830	Homo sapiens	Ki	nM	8.3
	19009119	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452360	=	Ki	nM	10.0	CHEMBL3830	Homo sapiens	Ki	nM	10.0
	19009120	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4534959	=	Ki	nM	6.3	CHEMBL3830	Homo sapiens	Ki	nM	6.3
	19009121	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	=	Ki	nM	8.2	CHEMBL3830	Homo sapiens	Ki	nM	8.2
	19009122	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CC(C)CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4571548	=	Ki	nM	6.2	CHEMBL3830	Homo sapiens	Ki	nM	6.2
	19009123	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCCS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4552310	=	Ki	nM	12.0	CHEMBL3830	Homo sapiens	Ki	nM	12.0
	19009124	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccc(F)cc4)c3)ccc12)C1CC1		CHEMBL4534571	=	Ki	nM	59.0	CHEMBL3830	Homo sapiens	Ki	nM	59.0
	19009125	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccccc4F)c3)ccc12)C1CC1		CHEMBL4473140	=	Ki	nM	22.0	CHEMBL3830	Homo sapiens	Ki	nM	22.0
	19009126	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4cccc(F)c4)c3)ccc12)C1CC1		CHEMBL4593649	=	Ki	nM	24.0	CHEMBL3830	Homo sapiens	Ki	nM	24.0
	19009127	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CCC4)c3)ccc12)C1CC1		CHEMBL4535040	=	Ki	nM	8.5	CHEMBL3830	Homo sapiens	Ki	nM	8.5
	19009128	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CCC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4447403	=	Ki	nM	32.0	CHEMBL3830	Homo sapiens	Ki	nM	32.0
	19009129	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CN(CC(F)(F)F)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4561238	=	Ki	nM	44.0	CHEMBL3830	Homo sapiens	Ki	nM	44.0
	19009130	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4582326	=	Ki	nM	39.0	CHEMBL3830	Homo sapiens	Ki	nM	39.0
	19009131	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CC(C)CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4522276	=	Ki	nM	30.0	CHEMBL3830	Homo sapiens	Ki	nM	30.0
	19009132	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(CC)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4472438	=	Ki	nM	33.0	CHEMBL3830	Homo sapiens	Ki	nM	33.0
	19009133	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4542463	=	Ki	nM	22.0	CHEMBL3830	Homo sapiens	Ki	nM	22.0
	19009134	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(C)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4470026	=	Ki	nM	20.0	CHEMBL3830	Homo sapiens	Ki	nM	20.0
	19009135	CHEMBL4345183	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged AAK1 kinase domain (31 to 396 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	=	Ki	nM	9.1	CHEMBL3830	Homo sapiens	Ki	nM	9.1
	19009190	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	=	IC50	nM	641.0	CHEMBL3830	Homo sapiens	IC50	nM	641.0
	19009191	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	=	IC50	nM	375.0	CHEMBL3830	Homo sapiens	IC50	nM	375.0
	19009192	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CC(C)CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4571548	=	IC50	nM	490.0	CHEMBL3830	Homo sapiens	IC50	nM	490.0
	19009193	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCCS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4552310	=	IC50	nM	655.0	CHEMBL3830	Homo sapiens	IC50	nM	655.0
	19009194	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccc(F)cc4)c3)ccc12)C1CC1		CHEMBL4534571	=	IC50	nM	1020.0	CHEMBL3830	Homo sapiens	IC50	nM	1020.0
	19009195	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccccc4F)c3)ccc12)C1CC1		CHEMBL4473140	=	IC50	nM	528.0	CHEMBL3830	Homo sapiens	IC50	nM	528.0
	19009196	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4cccc(F)c4)c3)ccc12)C1CC1		CHEMBL4593649	=	IC50	nM	379.0	CHEMBL3830	Homo sapiens	IC50	nM	379.0
	19009197	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CCC4)c3)ccc12)C1CC1		CHEMBL4535040	=	IC50	nM	192.0	CHEMBL3830	Homo sapiens	IC50	nM	192.0
	19009198	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CCC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4447403	=	IC50	nM	2710.0	CHEMBL3830	Homo sapiens	IC50	nM	2710.0
	19009199	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CN(CC(F)(F)F)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4561238	=	IC50	nM	3400.0	CHEMBL3830	Homo sapiens	IC50	nM	3400.0
	19009200	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4582326	=	IC50	nM	2350.0	CHEMBL3830	Homo sapiens	IC50	nM	2350.0
	19009201	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CC(C)CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4522276	=	IC50	nM	1530.0	CHEMBL3830	Homo sapiens	IC50	nM	1530.0
	19009202	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(CC)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4472438	=	IC50	nM	1470.0	CHEMBL3830	Homo sapiens	IC50	nM	1470.0
	19009203	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4542463	=	IC50	nM	1260.0	CHEMBL3830	Homo sapiens	IC50	nM	1260.0
	19009204	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(C)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4470026	=	IC50	nM	1790.0	CHEMBL3830	Homo sapiens	IC50	nM	1790.0
	19009205	CHEMBL4345187	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused AAK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	=	IC50	nM	770.0	CHEMBL3830	Homo sapiens	IC50	nM	770.0
	19009313	CHEMBL4345221	Inhibition of human wild type AAK1 (G25 to L333 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	>	Inhibition	%	80.0	CHEMBL3830	Homo sapiens	INH	%	80.0
Not Active	19039915	CHEMBL4351729	Inhibition of human AAK1 at 10 uM using peptide substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3830	Homo sapiens	INH		
	19059428	CHEMBL4357729	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3830	Homo sapiens	Activity	%	100.0
	19084220	CHEMBL4364406	Binding affinity to AAK1 in human HEK293/K562/placenta/HepG2 cell lysate mixture incubated for 45 mins by kinobeads based assay	B	Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1		CHEMBL4446892	=	Kd	nM	7943.28	CHEMBL3830	Homo sapiens	pKd		5.1
Active	19084236	CHEMBL4364406	Binding affinity to AAK1 in human HEK293/K562/placenta/HepG2 cell lysate mixture incubated for 45 mins by kinobeads based assay	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784		Activity			CHEMBL3830	Homo sapiens	Activity		
Active	19084237	CHEMBL4364406	Binding affinity to AAK1 in human HEK293/K562/placenta/HepG2 cell lysate mixture incubated for 45 mins by kinobeads based assay	B	O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C1CC1)C1CCC1		CHEMBL3605057		Activity			CHEMBL3830	Homo sapiens	Activity		
	19090001	CHEMBL4365575	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	79.0	CHEMBL3830	Homo sapiens	Activity	%	79.0
	19159256	CHEMBL4382360	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	72.0	CHEMBL3830	Homo sapiens	Activity	%	72.0
	19191269	CHEMBL4389557	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	75.0	CHEMBL3830	Homo sapiens	INH	%	75.0
	19191751	CHEMBL4389079	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	26.0	CHEMBL3830	Homo sapiens	INH	%	26.0
	19200039	CHEMBL4391182	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	13.0	CHEMBL3830	Homo sapiens	Activity	%	13.0
	19452129	CHEMBL4434092	Inhibition of AAK1 (unknown origin) at 0.1 uM relative to control	B	Nc1ncc(Br)c2ccc(-c3ccnc(F)c3)nc12		CHEMBL4471729	=	Inhibition	%	95.0	CHEMBL3830	Homo sapiens	INH	%	95.0
	19485778	CHEMBL4481507	Binding affinity to C-terminal AVI-tagged AAK1 (unknown origin) (31 to 396 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Ki	nM	53000.0	CHEMBL3830	Homo sapiens	Ki	uM	53.0
	19485779	CHEMBL4481507	Binding affinity to C-terminal AVI-tagged AAK1 (unknown origin) (31 to 396 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	>	Ki	nM	100000.0	CHEMBL3830	Homo sapiens	Ki	uM	100.0
	19485780	CHEMBL4481507	Binding affinity to C-terminal AVI-tagged AAK1 (unknown origin) (31 to 396 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	=	Ki	nM	78000.0	CHEMBL3830	Homo sapiens	Ki	uM	78.0
	22757231	CHEMBL4701088	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1		CHEMBL4744041	>	Activity	%	70.0	CHEMBL3830	Homo sapiens	Activity	%	70.0
	22757237	CHEMBL4701094	Binding affinity to human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1		CHEMBL4744041	=	Kd	nM	430.0	CHEMBL3830	Homo sapiens	Kd	nM	430.0
	22845461	CHEMBL4721742	Binding affinity to Nluc-tagged AAK1 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	2.43	CHEMBL3830	Homo sapiens	deltaTm	degrees C	2.43
	22886522	CHEMBL4728252	Binding affinity to AAK1 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL3830	Homo sapiens	deltaTm	degrees C	6.0
	22915573	CHEMBL4735375	Inhibition of human wild-type partial length AAK1 (G25 to L333 residues) expressed in bacterial system assessed as residual activity at 1 uM by kinomescan method relative to control	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccccc1		CHEMBL4789590	=	Activity	%	32.0	CHEMBL3830	Homo sapiens	Activity	%	32.0
	22926328	CHEMBL4737607	Inhibition of human partial length AAK1 (G25 to L333 residues) expressed in bacterial system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	44.0	CHEMBL3830	Homo sapiens	Activity	%	44.0
	23122414	CHEMBL4804765	Inhibition of human AAK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	84.0	CHEMBL3830	Homo sapiens	Activity	%	84.0
	23123109	CHEMBL4805353	Inhibition of human AAK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	91.0	CHEMBL3830	Homo sapiens	Activity	%	91.0
	23123776	CHEMBL4806020	Inhibition of DNA-tagged human AAK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	91.0	CHEMBL3830	Homo sapiens	Activity	%	91.0
	23124308	CHEMBL4806370	Inhibition of human AAK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL3830	Homo sapiens	Activity	%	94.0
	23124309	CHEMBL4806370	Inhibition of human AAK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	90.0	CHEMBL3830	Homo sapiens	Activity	%	90.0
	23213412	CHEMBL4822946	Inhibition of human recombinant AAK1 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	11.0	CHEMBL3830	Homo sapiens	INH	%	11.0
	23240569	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)C(C)C)ccc1-c1cnco1		CHEMBL4873273	=	IC50	nM	69.0	CHEMBL3830	Homo sapiens	IC50	nM	69.0
	23240570	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@@H](C)N)ccc1-c1cnco1		CHEMBL4857348	=	IC50	nM	1300.0	CHEMBL3830	Homo sapiens	IC50	nM	1300.0
	23240571	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4873120	=	IC50	nM	120.0	CHEMBL3830	Homo sapiens	IC50	nM	120.0
	23240572	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CCC[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4865219	=	IC50	nM	90.0	CHEMBL3830	Homo sapiens	IC50	nM	90.0
	23240573	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CCC[C@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4856131	=	IC50	nM	350.0	CHEMBL3830	Homo sapiens	IC50	nM	350.0
	23240574	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CCCC[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4853175	=	IC50	nM	65.0	CHEMBL3830	Homo sapiens	IC50	nM	65.0
	23240575	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CCCC[C@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4860241	=	IC50	nM	260.0	CHEMBL3830	Homo sapiens	IC50	nM	260.0
	23240576	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC[C@@H](C)[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4857865	=	IC50	nM	31.0	CHEMBL3830	Homo sapiens	IC50	nM	31.0
	23240577	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4877371	=	IC50	nM	12.0	CHEMBL3830	Homo sapiens	IC50	nM	12.0
	23240578	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4870589	=	IC50	nM	19.0	CHEMBL3830	Homo sapiens	IC50	nM	19.0
	23240579	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CCC(C)C)ccc1-c1cnco1		CHEMBL4857148	=	IC50	nM	71.0	CHEMBL3830	Homo sapiens	IC50	nM	71.0
	23240580	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)(C)C)ccc1-c1cnco1		CHEMBL4868996	=	IC50	nM	85.0	CHEMBL3830	Homo sapiens	IC50	nM	85.0
	23240581	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CN[C@H](CC(C)C)C(=O)Nc1ccc(-c2cnco2)c(OC)c1		CHEMBL4860340	=	IC50	nM	46.0	CHEMBL3830	Homo sapiens	IC50	nM	46.0
	23240582	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)C(CN)CC(C)C)ccc1-c1cnco1		CHEMBL4872087	=	IC50	nM	83.0	CHEMBL3830	Homo sapiens	IC50	nM	83.0
	23240583	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)C[C@@H](N)C(C)C)ccc1-c1cnco1		CHEMBL4871299	=	IC50	nM	127.0	CHEMBL3830	Homo sapiens	IC50	nM	127.0
	23240584	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC2CC2)ccc1-c1cnco1		CHEMBL4873626	=	IC50	nM	45.0	CHEMBL3830	Homo sapiens	IC50	nM	45.0
	23240585	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC2CCC2)ccc1-c1cnco1		CHEMBL4876045	=	IC50	nM	33.0	CHEMBL3830	Homo sapiens	IC50	nM	33.0
	23240586	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)C2CCCC2)ccc1-c1cnco1		CHEMBL4850768	=	IC50	nM	13.0	CHEMBL3830	Homo sapiens	IC50	nM	13.0
	23240587	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)C2CCCCC2)ccc1-c1cnco1		CHEMBL4874269	=	IC50	nM	18.0	CHEMBL3830	Homo sapiens	IC50	nM	18.0
	23240588	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC2CCCCC2)ccc1-c1cnco1		CHEMBL4847255	=	IC50	nM	480.0	CHEMBL3830	Homo sapiens	IC50	nM	480.0
	23240589	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)c2ccccc2)ccc1-c1cnco1		CHEMBL4850319	=	IC50	nM	42.0	CHEMBL3830	Homo sapiens	IC50	nM	42.0
	23240590	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)Cc2ccccc2)ccc1-c1cnco1		CHEMBL4878393	=	IC50	nM	630.0	CHEMBL3830	Homo sapiens	IC50	nM	630.0
	23240591	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CO)ccc1-c1cnco1		CHEMBL4859450	=	IC50	nM	5100.0	CHEMBL3830	Homo sapiens	IC50	nM	5100.0
	23240592	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)[C@H](C)O)ccc1-c1cnco1		CHEMBL4858951	=	IC50	nM	410.0	CHEMBL3830	Homo sapiens	IC50	nM	410.0
	23240593	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(N(C)C(=O)[C@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4876856	=	IC50	nM	12800.0	CHEMBL3830	Homo sapiens	IC50	nM	12800.0
	23240594	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)CCC(C)C)ccc1-c1cnco1		CHEMBL4875431	=	IC50	nM	80.0	CHEMBL3830	Homo sapiens	IC50	nM	80.0
	23240595	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)CC2CCCC2)ccc1-c1cnco1		CHEMBL4854187	=	IC50	nM	80.0	CHEMBL3830	Homo sapiens	IC50	nM	80.0
	23240596	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)Cc2ccccc2)ccc1-c1cnco1		CHEMBL419143	=	IC50	nM	430.0	CHEMBL3830	Homo sapiens	IC50	nM	430.0
	23240597	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H]2CCCCN2)ccc1-c1cnco1		CHEMBL4860264	=	IC50	nM	550.0	CHEMBL3830	Homo sapiens	IC50	nM	550.0
	23240598	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@@H]2NCCC[C@@H]2C(C)C)ccc1-c1cnco1		CHEMBL4871177	=	IC50	nM	10.0	CHEMBL3830	Homo sapiens	IC50	nM	10.0
	23240599	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H]2NCCC[C@H]2C(C)C)ccc1-c1cnco1		CHEMBL4869558	=	IC50	nM	360.0	CHEMBL3830	Homo sapiens	IC50	nM	360.0
	23240600	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cn[nH]c1		CHEMBL4867649	=	IC50	nM	15.0	CHEMBL3830	Homo sapiens	IC50	nM	15.0
	23240601	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cn[nH]n1		CHEMBL4854816	=	IC50	nM	49.0	CHEMBL3830	Homo sapiens	IC50	nM	49.0
	23240602	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cnn(C)c1		CHEMBL4845709	=	IC50	nM	3900.0	CHEMBL3830	Homo sapiens	IC50	nM	3900.0
	23240603	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cncs1		CHEMBL4875628	=	IC50	nM	190.0	CHEMBL3830	Homo sapiens	IC50	nM	190.0
	23240604	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-n1ccnc1		CHEMBL4875598	=	IC50	nM	3250.0	CHEMBL3830	Homo sapiens	IC50	nM	3250.0
	23240605	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-n1cncn1		CHEMBL4852601	=	IC50	nM	920.0	CHEMBL3830	Homo sapiens	IC50	nM	920.0
	23240606	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1ccncc1		CHEMBL4870048	=	IC50	nM	85.0	CHEMBL3830	Homo sapiens	IC50	nM	85.0
	23240607	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1ccnnc1		CHEMBL4865565	=	IC50	nM	110.0	CHEMBL3830	Homo sapiens	IC50	nM	110.0
	23240608	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1ccncn1		CHEMBL4855972	=	IC50	nM	290.0	CHEMBL3830	Homo sapiens	IC50	nM	290.0
	23240609	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1ccnc(Cl)c1		CHEMBL4856974	=	IC50	nM	240.0	CHEMBL3830	Homo sapiens	IC50	nM	240.0
	23240610	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1ccnc(N)c1		CHEMBL4877312	=	IC50	nM	150.0	CHEMBL3830	Homo sapiens	IC50	nM	150.0
	23240611	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CNc1cc(-c2ccc(NC(=O)[C@H](N)CC(C)C)cc2OC)ccn1		CHEMBL4866426	=	IC50	nM	450.0	CHEMBL3830	Homo sapiens	IC50	nM	450.0
	23240612	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cccnc1		CHEMBL4863639	=	IC50	nM	10200.0	CHEMBL3830	Homo sapiens	IC50	nM	10200.0
	23240613	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cncnc1		CHEMBL4858096	=	IC50	nM	5700.0	CHEMBL3830	Homo sapiens	IC50	nM	5700.0
	23240614	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)cc1		CHEMBL4862414	=	IC50	nM	170.0	CHEMBL3830	Homo sapiens	IC50	nM	170.0
	23240615	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	Cc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4864738	=	IC50	nM	48.0	CHEMBL3830	Homo sapiens	IC50	nM	48.0
	23240616	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CCc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4846012	=	IC50	nM	100.0	CHEMBL3830	Homo sapiens	IC50	nM	100.0
	23240617	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CCOc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4877595	=	IC50	nM	13.0	CHEMBL3830	Homo sapiens	IC50	nM	13.0
	23240618	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	IC50	nM	12.0	CHEMBL3830	Homo sapiens	IC50	nM	12.0
	23240619	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)(F)F)c1		CHEMBL4871551	=	IC50	nM	160.0	CHEMBL3830	Homo sapiens	IC50	nM	160.0
	23240620	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(F)c1		CHEMBL4845745	=	IC50	nM	43.0	CHEMBL3830	Homo sapiens	IC50	nM	43.0
	23240621	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(C#N)c1		CHEMBL4855163	=	IC50	nM	72.0	CHEMBL3830	Homo sapiens	IC50	nM	72.0
	23240622	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2ccncc2)cc1		CHEMBL4877470	=	IC50	nM	15.0	CHEMBL3830	Homo sapiens	IC50	nM	15.0
	23240623	CHEMBL4829123	Inhibition of recombinant GST-Xa-tagged human AAK1 (30 to 330 residues) using 5-FAM-labelled Alla-KEEQSQITSQVTGQIGWR-NH2 peptide as substrate incubated for 3 hrs in presence of ATP by electrophoretic analysis	B	CC(C)C1CCCNC1C(=O)Nc1ccc(-c2ccncc2)cc1		CHEMBL4845935	=	IC50	nM	17.0	CHEMBL3830	Homo sapiens	IC50	nM	17.0
	23240774	CHEMBL4829127	Binding affinity to AAK1 (unknown origin)	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	8.2	CHEMBL3830	Homo sapiens	Kd	nM	8.2
	23240776	CHEMBL4829129	Inhibition of AAK1 (unknown origin)	B	COc1ncccc1-c1cnn2ccc(N3CCN(C(=O)OC(C)C)CC3)nc12		CHEMBL4127773	=	IC50	nM	3.3	CHEMBL3830	Homo sapiens	IC50	nM	3.3
	23240777	CHEMBL4829129	Inhibition of AAK1 (unknown origin)	B	Cc1nccc2c1c(=O)n(C)c1cc(OC[C@@H](N)CC(C)C)c(C#N)cc21		CHEMBL4857123	=	IC50	nM	0.7	CHEMBL3830	Homo sapiens	IC50	nM	0.7
	23240778	CHEMBL4829129	Inhibition of AAK1 (unknown origin)	B	CN(CCNc1ccc2ncc(-c3ccc(C(N)=O)cc3)n2n1)C(=O)OC(C)(C)C		CHEMBL4855590	=	IC50	nM	4.8	CHEMBL3830	Homo sapiens	IC50	nM	4.8
	23240779	CHEMBL4829129	Inhibition of AAK1 (unknown origin)	B	COc1ccc(-c2cnc3[nH]cc(C#Cc4cccnc4)c3c2)cc1OC		CHEMBL4439128	=	IC50	nM	4.0	CHEMBL3830	Homo sapiens	IC50	nM	4.0
	23240781	CHEMBL4829131	Inhibition of human AAK1 expressed in HEK293 cells assessed as suppression of AP2 phosphorylation measured after 3 hrs by Western blot analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cnco1		CHEMBL4877371	=	IC50	nM	60.0	CHEMBL3830	Homo sapiens	IC50	nM	60.0
	23240782	CHEMBL4829131	Inhibition of human AAK1 expressed in HEK293 cells assessed as suppression of AP2 phosphorylation measured after 3 hrs by Western blot analysis	B	COc1cc(NC(=O)[C@@H]2NCCC[C@@H]2C(C)C)ccc1-c1cnco1		CHEMBL4871177	=	IC50	nM	105.0	CHEMBL3830	Homo sapiens	IC50	nM	105.0
	23240783	CHEMBL4829131	Inhibition of human AAK1 expressed in HEK293 cells assessed as suppression of AP2 phosphorylation measured after 3 hrs by Western blot analysis	B	COc1cc(NC(=O)[C@H](N)CC(C)C)ccc1-c1cn[nH]c1		CHEMBL4867649	=	IC50	nM	190.0	CHEMBL3830	Homo sapiens	IC50	nM	190.0
	23240784	CHEMBL4829131	Inhibition of human AAK1 expressed in HEK293 cells assessed as suppression of AP2 phosphorylation measured after 3 hrs by Western blot analysis	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	IC50	nM	51.0	CHEMBL3830	Homo sapiens	IC50	nM	51.0
	23240822	CHEMBL4829147	Inhibition of human wild-type AAK1 (G25 to L333 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	Activity	%	18.0	CHEMBL3830	Homo sapiens	Activity	%	18.0
Not Active	23317249	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	89.0	CHEMBL3830	Homo sapiens	% Control	%	89.0
Not Active	23317717	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	98.0	CHEMBL3830	Homo sapiens	% Control	%	98.0
Not Active	23318391	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL3830	Homo sapiens	% Control	%	87.0
Not Active	23318867	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	94.0	CHEMBL3830	Homo sapiens	% Control	%	94.0
Not Active	23319507	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23319979	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23320657	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23321125	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23321755	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	95.0	CHEMBL3830	Homo sapiens	% Control	%	95.0
Not Active	23322223	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	90.0	CHEMBL3830	Homo sapiens	% Control	%	90.0
Not Active	23322912	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	91.0	CHEMBL3830	Homo sapiens	% Control	%	91.0
Not Active	23323380	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23324234	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23324869	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	78.0	CHEMBL3830	Homo sapiens	% Control	%	78.0
Not Active	23325337	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23325984	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	88.0	CHEMBL3830	Homo sapiens	% Control	%	88.0
Not Active	23326452	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23327152	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	99.0	CHEMBL3830	Homo sapiens	% Control	%	99.0
Not Active	23327620	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23328207	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	79.0	CHEMBL3830	Homo sapiens	% Control	%	79.0
Not Active	23328675	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	83.0	CHEMBL3830	Homo sapiens	% Control	%	83.0
Not Active	23329621	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23330089	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23330845	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	99.0	CHEMBL3830	Homo sapiens	% Control	%	99.0
Not Active	23331313	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23331900	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	95.9	CHEMBL3830	Homo sapiens	% Control	%	95.9
Not Active	23332368	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23333084	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23333723	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	95.0	CHEMBL3830	Homo sapiens	% Control	%	95.0
Not Active	23334191	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	94.0	CHEMBL3830	Homo sapiens	% Control	%	94.0
Not Active	23335170	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL3830	Homo sapiens	% Control	%	99.0
Not Active	23335638	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23336265	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	96.0	CHEMBL3830	Homo sapiens	% Control	%	96.0
Not Active	23336733	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23337814	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23338282	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23338894	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23339362	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23339999	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	94.0	CHEMBL3830	Homo sapiens	% Control	%	94.0
Not Active	23340467	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23341124	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23341592	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23342208	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23342676	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23343306	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23343774	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	90.0	CHEMBL3830	Homo sapiens	% Control	%	90.0
Not Active	23344412	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23344985	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23345453	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	77.0	CHEMBL3830	Homo sapiens	% Control	%	77.0
Not Active	23346030	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23346499	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	85.7	CHEMBL3830	Homo sapiens	% Control	%	85.7
Not Active	23347109	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	52.5	CHEMBL3830	Homo sapiens	% Control	%	52.5
Not Active	23347590	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23348169	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23348637	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23349224	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	96.0	CHEMBL3830	Homo sapiens	% Control	%	96.0
Not Active	23349842	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23350310	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23350915	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23351383	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23352407	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23352875	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	84.0	CHEMBL3830	Homo sapiens	% Control	%	84.0
Not Active	23353757	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23354225	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23354957	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23355425	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23356061	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23356529	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23357138	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23357785	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	74.0	CHEMBL3830	Homo sapiens	% Control	%	74.0
Not Active	23358253	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23358839	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23359437	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23359905	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23360490	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23360958	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23361531	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23362067	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23362535	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	96.0	CHEMBL3830	Homo sapiens	% Control	%	96.0
Not Active	23364177	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	78.0	CHEMBL3830	Homo sapiens	% Control	%	78.0
Not Active	23364645	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	98.0	CHEMBL3830	Homo sapiens	% Control	%	98.0
Not Active	23365384	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	91.0	CHEMBL3830	Homo sapiens	% Control	%	91.0
Not Active	23365927	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	79.0	CHEMBL3830	Homo sapiens	% Control	%	79.0
Not Active	23366517	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23366985	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23367863	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	91.0	CHEMBL3830	Homo sapiens	% Control	%	91.0
Not Active	23368331	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL3830	Homo sapiens	% Control	%	95.0
Not Active	23368930	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	60.0	CHEMBL3830	Homo sapiens	% Control	%	60.0
Not Active	23369398	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	85.0	CHEMBL3830	Homo sapiens	% Control	%	85.0
Not Active	23370366	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	81.0	CHEMBL3830	Homo sapiens	% Control	%	81.0
Not Active	23370834	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	90.0	CHEMBL3830	Homo sapiens	% Control	%	90.0
Not Active	23371643	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	92.0	CHEMBL3830	Homo sapiens	% Control	%	92.0
Not Active	23372111	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	90.0	CHEMBL3830	Homo sapiens	% Control	%	90.0
	23373704	CHEMBL4885481	AAK1(AAK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3830	Homo sapiens	pIC50		6.0
Not Active	23375538	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23376006	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23376584	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23377053	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23377911	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23378379	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23379546	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23380014	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23380708	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23381356	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23381824	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3830	Homo sapiens	% Control	%	100.0
Not Active	23382448	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	80.0	CHEMBL3830	Homo sapiens	% Control	%	80.0
Slightly Active	23382916	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	27.0	CHEMBL3830	Homo sapiens	% Control	%	27.0
Active	23383565	CHEMBL4887227	AAK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	13.0	CHEMBL3830	Homo sapiens	% Ctrl	%	13.0
Active	23383566	CHEMBL4887227	AAK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	4.0	CHEMBL3830	Homo sapiens	% Ctrl	%	4.0
Not Active	23383567	CHEMBL4887227	AAK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	101.0	CHEMBL3830	Homo sapiens	% Ctrl	%	101.0
Slightly Active	23384077	CHEMBL4887159	Dose response measurement (AAK1)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		IC50	nM	272.0	CHEMBL3830	Homo sapiens	IC50	nM	272.0
Not Active	23384080	CHEMBL4887162	NanoBRET (SGC-FFM) (AAK1)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12	Non standard unit for type	CHEMBL4522930		IC50	µM	7.0	CHEMBL3830	Homo sapiens	IC50	µM	7.0
Not Active	23384168	CHEMBL4887763	AAK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	7.44	CHEMBL3830	Homo sapiens	% inhibition	%	7.44
Not Active	23384831	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	84.0	CHEMBL3830	Homo sapiens	% Control	%	84.0
Not Active	23385298	CHEMBL4879555	KinomeScan assay: inhibition of AAK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	96.0	CHEMBL3830	Homo sapiens	% Control	%	96.0
